CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Mark G. Woodcock, John T. Le et al.|Nature|2024Cited by 171
Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer.Ferdinandos Skoulidis, John V. Heymach, Kathryn C. Arbour et al.|Journal of Clinical Oncology|2019Cited by 102
MA11.11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLCFerdinandos Skoulidis, Jack A. Roth, Kathryn C. Arbour et al.|Journal of Thoracic Oncology|2019Cited by 3